Join
Live feed
·
PRReleasevia Quantisnow
AbbVie Inc. logo
Amgen Inc. logo
Apogee Therapeutics Inc. logo
+7

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight

ByQuantisnow·Wall Street's wire, on your screen.
ABBV· AbbVie Inc.AMGN· Amgen Inc.APGE· Apogee Therapeutics Inc.CNTB· Connect Biopharma Holdings LimitedINCY· Incyte Corp.LLY· Eli Lilly and Company
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABBV (AbbVie Inc.), AMGN (Amgen Inc.), APGE (Apogee Therapeutics Inc.) and more on Quantisnow.